Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILMENIDINE vs RIPRETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILMENIDINE vs RIPRETINIB: Safety Overview

Metric RILMENIDINE RIPRETINIB
Total FAERS Reports 899 4,432
Deaths Reported 103 465
Death Rate 11.5% 10.5%
Hospitalizations 536 948
Average Patient Age 73.4 yrs 66.8 yrs
% Female Patients 65.3% 45.3%
FDA Approval Date N/A May 15, 2020
Manufacturer N/A Deciphera Pharmaceuticals, LLC
Route N/A ORAL
Marketing Status N/A Prescription